Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

JNJ

Johnson & Johnson

Dec 08 • 04:00PM ET

154.42

Dollar change -0.98
Percentage change -0.63	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	DJIA, S&P 500	P/E	29.47	EPS (ttm)	5.24	Insider Own	0.17%	Shs Outstand	2.61B	Perf Week	-2.50%
Market Cap	371.73B	Forward P/E	14.37	EPS next Y	10.75	Insider Trans	-1.14%	Shs Float	2.40B	Perf Month	2.71%
Income	13.64B	PEG	5.67	EPS next Q	2.37	Inst Own	70.79%	Short Float / Ratio	0.55% / 1.95	Perf Quarter	-5.07%
Sales	95.35B	P/S	3.90	EPS this Y	-1.31%	Inst Trans	-0.39%	Short Interest	13.19M	Perf Half Y	-3.49%
Book/sh	29.59	P/B	5.22	EPS next Y	7.28%	ROA	7.56%	Target Price	175.84	Perf Year	-12.84%
Cash/sh	9.77	P/C	15.81	EPS next 5Y	5.20%	ROE	17.70%	52W Range	144.95 - 181.04	Perf YTD	-12.58%
Dividend	4.60	P/FCF	23.62	EPS past 5Y	70.31%	ROI	14.02%	52W High	-14.70%	Beta	0.53
Dividend %	2.98%	Quick Ratio	0.96	Sales past 5Y	4.55%	Gross Margin	68.02%	52W Low	6.53%	ATR	2.06
Employees	152700	Current Ratio	1.21	Sales Q/Q	-10.36%	Oper. Margin	26.68%	RSI (14)	53.41	Volatility	1.26% 1.32%
Optionable	Yes	Debt/Eq	0.42	EPS Q/Q	18.10%	Profit Margin	14.31%	Rel Volume	0.91	Prev Close	155.40
Shortable	Yes	LT Debt/Eq	0.37	Earnings	Oct 17 BMO	Payout	66.07%	Avg Volume	6.78M	Price	154.42
Recom	2.17	SMA20	1.58%	SMA50	1.07%	SMA200	-3.10%	Volume	6,146,037	Change	-0.63%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform	$200
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$173
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform	$180 → $183
Mar-02-22	Resumed	BofA Securities	Neutral	$185
Dec-17-21	Initiated	Goldman	Neutral	$161
Dec-15-21	Reiterated	Citigroup	Buy	$192 → $195
Sep-07-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$187
May-28-21	Resumed	Morgan Stanley	Overweight	$187
Apr-28-20	Downgrade	UBS	Buy → Neutral	$163 → $160
Apr-22-20	Upgrade	BofA/Merrill	Neutral → Buy	$150 → $175

Show Previous Ratings

Today 01:05PM	5 Dow Stocks Billionaires Like The Most (Insider Monkey)
11:35AM	5 Healthcare Stocks Billionaires Like the Most (Insider Monkey)
Dec-09-23 05:51AM	3 Dividend Stocks You Can Safely Hold for Decades (Motley Fool)
Dec-07-23 04:15PM	Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
12:47PM	20 Countries with Free Health Care (Insider Monkey)
11:50AM	Loading…
11:50AM	15 Stocks ChatGPT Says Will Make Me Rich in 10 Years (Insider Monkey)
11:20AM	Top 20 Most Valuable American Companies Today (Insider Monkey)
08:52AM	A CEO contender left Johnson & Johnson. Was she penalized for saying she wanted to be a CEO? (Fortune)
Dec-06-23 12:35PM	Johnson & Johnson says it's finally making 'progress' on disturbing cancer lawsuits (TheStreet.com)
11:29AM	J&J (JNJ) Announces 2024 and Long-Term Financial Outlook (Zacks)
09:19AM	Pharma Stocks With Nice Dividends: The RX Investors Need (Barrons.com)
08:58AM	Analyst Report: Johnson & Johnson (Morningstar Research)
06:59AM	His dad worked on the factory floor at Johnson & Johnson. Now hes the CFO (Fortune)
05:55AM	5 takeaways from J&Js investor day (MedTech Dive)
01:21AM	J&J hernia mesh settlement prompts judge to dismiss more than 200 cases (MedTech Dive)
06:23PM	Loading…
Dec-05-23 06:23PM	J&J says it has settled some talc claims, will continue bankruptcy strategy (Reuters)
05:45PM	Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
12:03PM	UPDATE 1-Johnson & Johnson forecasts as much as 6% sales growth in 2024 (Reuters)
11:12AM	5 Best Healthcare Dividend Stocks To Buy Now (Insider Monkey)
08:07AM	Johnson & Johnson Stock Edges Higher After Guidance Release (Barrons.com)
07:57AM	Johnson & Johnson Targets Sales Growth in Years Ahead (The Wall Street Journal)
07:40AM	J&J's (JNJ) Bladder Cancer Drug Gets FDA's Breakthrough Tag (Zacks)
07:18AM	Midday movers: CVS Health, Apple, and more (Investing.com)
07:17AM	Johnson & Johnson forecasts as much as 6% sales growth in 2024 (Reuters)
07:15AM	Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review (Business Wire)
06:01AM	J&J pitches investors on sales growth from cancer, immune disease drugs (BioPharma Dive)
Dec-04-23 05:30AM	The Executives Who Could Be Johnson & Johnsons Next CEO (The Wall Street Journal)
Dec-03-23 08:00AM	The Second-Largest U.S. Pension Slashed Its AMC Stock Stake (Barrons.com)
08:00AM	Second-Largest U.S. Pension Sold AMC, NIO, Spotify, and JNJ Stock (Barrons.com)
07:00AM	Warren Buffett sold a whopping $7B worth of stock in Q3 and even unloaded 2 giant American 'dividend kings.' But here's why the Oracle of Omaha could be dead wrong (Moneywise)
05:30AM	Loading…
05:30AM	Warren Buffett Just Closed His Position in This Dividend Giant. Should You? (Motley Fool)
Dec-02-23 02:05PM	JP Morgans Top 15 Stock Picks for 2023 and Now (Insider Monkey)
06:14AM	REUTERS NEWS SCHEDULE AT 11 a.m. GMT/6 a.m. ET (Reuters)
Dec-01-23 12:33PM	Johnson & Johnson Stock Gains a Bull Ahead of Analyst Day (Barrons.com)
09:32AM	Elastic upgraded, Alibaba downgraded: Wall Street's top analyst calls (The Fly)
Nov-30-23 05:16PM	UPDATE 2-Pfizer is sued by Texas over COVID vaccine claims (Reuters)
04:30PM	Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors (Business Wire)
11:04AM	UPDATE 1-Turkey launches investigation into 19 pharma companies (Reuters)
08:40AM	Johnson & Johnson MedTech Acquires Laminar, Inc. (Business Wire)
07:21AM	J&J heats up LAA closure competition with $400M Laminar buy (MedTech Dive)
05:30AM	J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off? (The Wall Street Journal)
02:13AM	Turkey launches investigation into 19 pharma companies (Reuters)
Nov-29-23 06:04PM	20 Countries With The Lowest Retirement Ages in The World (Insider Monkey)
05:45PM	Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note (Zacks)
05:18PM	15 States with the Best Economy Right Now (Insider Monkey)
09:00AM	Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
05:00AM	3 medtech spinoffs that reshaped the industry in 2023, and what to expect next (MedTech Dive)
Nov-28-23 01:34PM	AWS expands big pharma partnerships on manufacturing, AI, and R&D (Yahoo Finance)
01:34PM	AWS expands big pharma partnerships in manufacturing, AI, and R&D (Yahoo Finance)
06:30AM	'Things were way tougher': Charlie Munger's blunt message to whiners worried about 'hardship' plus 3 stocks Warren Buffett's right-hand man uses to supercharge his finances (Moneywise)
05:41AM	2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now (Motley Fool)
Nov-27-23 09:56AM	Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls (The Fly)
06:03AM	Johnson & Johnson: An Exploration into Its Intrinsic Value (GuruFocus.com)
05:30AM	5 Stocks You Can Confidently Invest $500 In Right Now (Motley Fool)
Nov-26-23 07:15AM	Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio (Motley Fool)
06:51AM	15 Best Drug Stocks To Invest In (Insider Monkey)
06:30AM	Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying? (Motley Fool)
05:56AM	12 Best Medical Technology Stocks To Buy Now (Insider Monkey)
Nov-25-23 04:22PM	11 Best Fortune 500 Dividend Stocks To Buy Now (Insider Monkey)
Nov-24-23 08:20AM	3 Dividend Stocks You Can Safely Hold for Decades (Motley Fool)
03:49AM	Goldman Sachs Value Stocks: Top 12 Stock Picks (Insider Monkey)
12:07AM	South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs (Associated Press Finance)
Nov-23-23 05:11PM	15 Best Income Stocks To Invest In (Insider Monkey)
Nov-22-23 01:01PM	Worried About Market Volatility? Invest In These High-Yield Dividend Stocks For Consistent Passive Income (Benzinga)
05:06AM	5 Longtime Holdings Warren Buffett Completely Sold During the Third Quarter (Motley Fool)
Nov-21-23 03:20PM	A Golden Age of Vaccines Is Here. What It Means for You. (Barrons.com)
12:41PM	J&J (JNJ) Seeks Expanded Use of Lung Cancer Drug Rybrevant (Zacks)
11:53AM	17 Stocks Warren Buffett Just Bought and Sold (Insider Monkey)
08:32AM	5 Stocks Hedge Funds Are Talking About (Insider Monkey)
Nov-20-23 01:25PM	Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug (TheStreet.com)
12:02PM	Bristol-Myers Squibb, 2seventy Bio Shares Fall as FDA Delays Decision on Cancer Drug (Investopedia)
07:15AM	Bayer ends large blood thinner trial for inferior efficacy (BioPharma Dive)
06:52AM	20 Most Valuable Healthcare Companies in the World (Insider Monkey)
05:56AM	25 States with the Highest Poverty Rates in the US (Insider Monkey)
05:04AM	Johnson & Johnson's Dividend Analysis (GuruFocus.com)
Nov-19-23 02:05PM	Ray Dalios Latest 13F Portfolio: Top 15 Stocks (Insider Monkey)
Nov-17-23 09:21AM	Morning Brew: Market Eyes Late-Cycle Quality Stocks and Housing Gains (GuruFocus.com)
06:03AM	Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win? (Motley Fool)
Nov-16-23 06:30PM	J&J settles first talc cases to go to trial after failed bankruptcies (Reuters)
12:13PM	10 States With The Most Doctors Per Capita In 2023 (Insider Monkey)
11:30AM	Johnson & Johnson (JNJ) Down 2.6% Since Last Earnings Report: Can It Rebound? (Zacks)
07:30AM	Johnson & Johnson to Host Enterprise Business Review (Business Wire)
05:50AM	Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On (Motley Fool)
Nov-15-23 04:31PM	15 Developed Countries with Lowest Autism Rates (Insider Monkey)
11:57AM	12 Monthly Dividend Stocks with Over 5% Yield (Insider Monkey)
10:07AM	2 Dividend Stocks Near Their 52-Week Lows to Buy and Hold Forever (Motley Fool)
09:57AM	Berkshire Hathaway exits GM, Johnson & Johnson positions (Yahoo Finance Video)
09:00AM	Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know (Zacks)
Nov-14-23 05:30AM	3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing (Motley Fool)
Nov-13-23 04:05PM	Ray Dalio's Bridgewater Associates Adjusts Portfolio, Notably Reduces Johnson & Johnson Stake (GuruFocus.com)
02:14PM	Dividend Kings Ranked By Yield: Top 25 (Insider Monkey)
06:02AM	Unlocking Intrinsic Value: Analysis of Johnson & Johnson (GuruFocus.com)
Nov-11-23 05:00AM	Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth (Motley Fool)
Nov-10-23 07:48AM	13 Best DRIP Stocks To Own (Insider Monkey)
07:38AM	12 Dogs of the Dow Dividend Stocks to Buy (Insider Monkey)
Nov-09-23 05:21AM	2 Magnificent Dow Stocks to Buy in November and 1 to Avoid Like the Plague (Motley Fool)
04:06AM	11 Best S&P 500 Stocks To Buy According to Ray Dalios Bridgewater Associates (Insider Monkey)
Nov-08-23 02:53PM	15 Best American Dividend Stocks To Buy Now (Insider Monkey)
09:45AM	3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever (Motley Fool)
Nov-07-23 09:21AM	Morning Brew: Johnson & Johnson's Ottava Delay, Uber's Q3 Miss, and Intel's Foundry Business (GuruFocus.com)

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women's Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hait William	See Remarks	Jul 26	Option Exercise	90.44	14,698	1,329,287	102,445	Jul 27 05:52 PM
Hait William	See Remarks	Jul 26	Sale	172.00	14,698	2,528,056	87,747	Jul 27 05:52 PM
Fasolo Peter	Exec VP, Chief HR Officer	Jul 25	Sale	170.32	20,000	3,406,498	102,696	Jul 27 05:52 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Jun 12	Sale	160.00	12,465	1,994,400	65,934	Jun 14 04:19 PM
Swanson James D.	See Remarks	Mar 06	Sale	154.66	1,062	164,199	9,215	Mar 08 04:16 PM
McEvoy Ashley	EVP, WW Chair, MedTech	Feb 10	Option Exercise	0.00	2,999	0	44,812	Feb 14 04:36 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 10	Option Exercise	0.00	3,570	0	130,026	Feb 14 04:36 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 10	Option Exercise	0.00	5,220	0	300,940	Feb 14 04:37 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 10	Option Exercise	0.00	2,078	0	116,754	Feb 14 04:35 PM
Mongon Thibaut	Exec VP, WW Chair, Cons Health	Feb 10	Option Exercise	0.00	2,285	0	59,461	Feb 14 04:35 PM
Hait William	See Remarks	Feb 10	Option Exercise	0.00	3,856	0	84,092	Feb 14 04:35 PM
Wolk Joseph J	Exec VP, CFO	Feb 10	Option Exercise	0.00	3,449	0	39,261	Feb 14 04:36 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 10	Option Exercise	0.00	1,807	0	73,118	Feb 14 04:37 PM
Swanson James D.	See Remarks	Feb 10	Option Exercise	0.00	1,291	0	8,355	Feb 14 04:34 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 10	Option Exercise	0.00	1,592	0	17,259	Feb 14 04:35 PM
Decker Robert J	VP Corporate Controller	Feb 10	Option Exercise	0.00	581	0	16,054	Feb 14 04:35 PM
Gorsky Alex	Director	Jan 17	Option Exercise	72.54	547,692	39,729,578	1,133,194	Jan 18 04:39 PM
Duato Joaquin	CEO and Chairman of the Board	Jan 17	Option Exercise	72.54	148,538	10,774,947	394,515	Jan 18 04:39 PM
Wolk Joseph J	Exec VP, CFO	Dec 13	Option Exercise	88.19	14,781	1,303,589	50,593	Dec 15 04:34 PM
Wolk Joseph J	Exec VP, CFO	Dec 13	Sale	179.60	14,781	2,654,661	35,812	Dec 15 04:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ

Johnson & Johnson

Upgrade your FINVIZ experience